The increasing use of Ozempic for modest weight loss has sparked intense debate within medical communities, raising questions about effectiveness, safety, and

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.

Ozempic, Wegovy and Mounjaro have radically transformed the world of weight loss. Health experts know there are plenty of foods — probably in your pantry right now — that affect the body like those medications.

Ozempic is arguably the buzziest buzzword in our culture today. But we still have plenty of questions about the type 2 diabetes medication-turned- weight-loss wonder drug—like how long does it take for Ozempic to work?